Challenges in Crohn's disease.
Rutgeerts
Paul J
PJ
Faculty of Medicine, Gastroenterology Section, University of Leuven, Leuven, Belgium.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001691:Biological Therapy; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab